Home / Research library / Vilon
Vilon: molecular data, studies & sources
Vilon is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C11H21N3O5
- Molecular weight (MW)
- 275.30 g/mol
- PubChem compound ID
- 7010502
- Record title
- Lysylglutamic acid
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 7010502 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- (2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]pentanedioic acid
- InChIKey
- UGTZHPSKYRIGRJ-YUMQZZPRSA-N
- SMILES
- C(CCN)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)N
Identifiers & sequence
- PubChem CID
- 7010502
- CAS Registry Number
- 45234-02-4via ChemIDplus, EPA DSSTox, FDA GSRS
- FDA UNII
- H34V7IM5ML
- ChEMBL ID
- CHEMBL365790
- InChIKey
- UGTZHPSKYRIGRJ-YUMQZZPRSA-N
Peptide sequence · 2 residues (one-letter code; X marks a residue without a one-letter code)
KE
Condensed notation with terminal groups and non-standard residues
H-Lys-Glu-OH
Source: PubChem Biologic Line Notation. A reference sequence for the record, not an analysis of a supplied batch.
CAS numbers are published only from ChemIDplus, EPA DSSTox or the FDA Global Substance Registration System; UNII codes are confirmed in FDA GSRS by structure, sequence or exact name. Checked 2026-10-07.
Calculated molecular descriptors
| Monoisotopic (exact) mass | 275.1481 Da |
|---|---|
| Heavy atoms | 19 |
| Hydrogen-bond donors | 5 |
| Hydrogen-bond acceptors | 5 |
| Rotatable bonds | 10 |
| Topological polar surface area | 155.7 Ų |
| Calculated logP (Crippen) | -1.12 |
| Rings | 0 |
| Stereocenters | 2 |
| Formal charge | 0 |
Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list Vilon as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.
Registry check 2026-10-01 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received Vilon, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
- Human study · PubMed trial index Compound given to participants
[Effect of thymomimetic vilon on blood coagulation system and fibrinolisis in diabetes mellitus type 1 patients of different age].
Kuznik BI, Kolesnichenko LR, Kliuchereva NN et al. · Advances in gerontology = Uspekhi gerontologii · 2006
PMID 17152731
- Human study · PubMed trial index Compound given to participants
[Effect of vilon on the immunity status and coagulation hemostasis in patients of different age with diabetes mellitus].
Kuznik BI, Isakova NV, Kliuchereva NN et al. · Advances in gerontology = Uspekhi gerontologii · 2007
PMID 18306698
- Human study · PubMed trial index Compound given to participants
[Application of peptide bioregulator in complex treatment of elderly cancer patients].
Ias'kevich LS, Krutilina NI, Kostetskaia TV et al. · Advances in gerontology = Uspekhi gerontologii · 2005
PMID 16075684
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Research publication · design requires review
Short Exogenous Peptides Regulate Expression of CLE, KNOX1, and GRF Family Genes in Nicotiana tabacum.
Fedoreyeva LI, Dilovarova TA, Ashapkin VV et al. · Biochemistry. Biokhimiia · 2017
PMID 28371610 · DOI: 10.1134/S0006297917040149
- Research publication · design requires review
Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.
Avolio F, Martinotti S, Khavinson VK et al. · International journal of molecular sciences · 2022
PMID 35408963 · DOI: 10.3390/ijms23073607
- Preclinical / laboratory research
Tissue-specific effects of peptides.
Khavinson VK · Bulletin of experimental biology and medicine · 2001
PMID 11713572 · DOI: 10.1023/a:1013058701974
- Preclinical / laboratory research
Peptidegic stimulation of differentiation of pineal immune cells.
Linkova NS, Khavinson VKh, Chalisova NI et al. · Bulletin of experimental biology and medicine · 2011
PMID 22803057 · DOI: 10.1007/s10517-011-1470-1
- Preclinical / laboratory research
[Investigation of antihypoxic properties of short peptides].
Kozina LS · Advances in gerontology = Uspekhi gerontologii · 2008
PMID 18546825
Vilon supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Vilon for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| American PeptidesUSD | 20mg Vial1 recorded offers | 20mg Vial · $60.00Recorded out of stock · Checked Oct 13, 2026Supplier listing, Vilon 20mg Vial, American Peptides, opens in a new tab |
| Amino USAUSD | 20mg Vial1 recorded offers | 20mg Vial · $40.00Checked Oct 13, 2026Supplier listing, Vilon 20mg Vial, Amino USA, opens in a new tab |
| Cenexa LabsUSD | 10mg Vial · 20mg Vial2 recorded offers | 10mg Vial · $38.99Checked Oct 13, 2026Supplier listing, Vilon 10mg Vial, Cenexa Labs, opens in a new tab |
Reference sources & further reading
- PubChem compound record 7010502 — chemical identity and structure.
- FDA Global Substance Registration System: UNII H34V7IM5ML — substance identity, names and codes.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
Bronchogen
C18H30N4O9
446.5 g/mol · PubChem CID 11690869
6 selected publications · 0 human intervention studies
Cardiogen
Molecular identity needs further verification
1 selected publication · 0 human intervention studies
Cartalax
C12H19N3O8
333.29 g/mol · PubChem CID 87815447
0 selected publications · 0 human intervention studies
Chonluten
C11H17N3O8
319.27 g/mol · PubChem CID 194641
1 selected publication · 0 human intervention studies
Cortagen
C17H26N4O9
430.4 g/mol · PubChem CID 18439621
5 selected publications · 0 human intervention studies
Epithalon
C14H22N4O9
390.35 g/mol · PubChem CID 219042
4 selected publications · 1 human intervention study